Category Archives: Drugs

This Shield of Patents Protects the World’s Best-Selling Drug

Over Humira’s lifetime, AbbVie has secured more than 100 patents to prevent anyone from attempting to copy the biologic, with $16 billion in annual sales. By Cynthia Koons Humira, a treatment for inflammatory diseases such as rheumatoid arthritis and psoriasis … Continue reading

Posted in Biologics/Biosimilars, Uncategorized | Leave a comment

Delhi HC seeks AAP govt report on plea for free treatment of Hepatitis C

Source: PTI Published: Zee News A bench of Acting Chief Justice Gita Mittal and Justice C Hari Shankar also issued notice to the Delhi Government on the petition which sought direction to identify and publicise the names of hospitals, laboratories and medical … Continue reading

Posted in Drug prices, Drugs, Hepatitis C, Uncategorized | Tagged , | Leave a comment

Draft Pharmaceutical Policy, 2017

Source: All India Drug Action Network (AIDAN) The Department of Pharmaceuticals has circulated a Draft Pharmaceutical Policy, 2017 which can be accessed here. The draft policy identifies the following key objectives: a. Making essential drugs accessible at affordable prices to the … Continue reading

Posted in API, Biologics/Biosimilars, Evergreening, Innovation, IPR, Patent, R&D, Uncategorized | Leave a comment

No logic in extending length of patents

Granting a longer term for pharmaceutical patents will result in delays in the entry of generic versions and could adversely affect access to medicines   By Feroz Ali, Live Mint | July 28, 2017 A proposal to further extend the … Continue reading

Posted in Biologics/Biosimilars, Data Exclusivity, Patent, Patent Term Extension, Regional Comprehensive Economic Partnership, TRIPS, TRIPS flexibilities, TRIPS plus, TRIPS&IP rights, Uncategorized | Leave a comment

HIV+ community stage protest to drop harmful provisions in RCEP; arrested & released

Hyderabad, 24 July 2017: About 30 HIV positive people were arrested at Hotel Novotel in Hitec City and taken to Narsingi police station as they raised slogans and took out a flash protest against the harmful provisions in the Regional Comprehensive … Continue reading

Posted in FTA, Generics, HIV/Aids, Regional Comprehensive Economic Partnership, Uncategorized | Leave a comment

Regional Comprehensive Economic Partnership: Boosting trade or extending monopolies for big pharma?

Published: The Huffington Post India By Leena Menghaney, Head—South Asia, Médecins Sans Frontières (MSF) Access Campaign. MÉDECINS SANS FRONTIÈRES (MSF) Officials from the 16 countries negotiating the Regional Comprehensive Economic Partnership (RCEP) trade deal—which includes the ten ASEAN member states, … Continue reading

Posted in Data Exclusivity, FTA, Generics, Patent, Patent Term Extension, Regional Comprehensive Economic Partnership, TRIPS, TRIPS plus, Uncategorized | Leave a comment

Hyderabad: NGOs hold protest against RCEP talks

Posted in FTA, Generics, HIV/Aids, Regional Comprehensive Economic Partnership, Uncategorized | Leave a comment